Abstract
Long-term potentiation is widely used as a model for memory formation. Recently, much information concerning this topic like the involvement of protein kinase C, arachidonic acid andN-methyl-d-aspartate receptors has been reported. In this review recent discoveries concerning long-term potentiation and the pharmacological implications for the development of cognition-enhancing drugs are discussed.
Similar content being viewed by others
References
Cajal SR. Histologie du système nerveux de l'homme et des vertebres. Vol. II. Paris: Malone, 1911.
Hebb DO. The organization of behaviour. New York: John Wiley & Sons, 1949:86–98.
Milner B. Disorders of learning and memory after temporal lobe lesions in man. Clin Neurosurg 1972;19:421–46.
Squire LR. Mechanisms of memory. Science 1986;232:1612–9.
Zola-Morgan S, Squire LR, Amaral DG. Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 1986;6:2950–67.
Lømo T. Frequency potentiation of excitatory synaptic activity in the dentate area of the hippocampal formation. Acta Physiol Scand 1966;68:128–36.
Bliss TVP, Lømo T. Long-lasting potentiation of synaptic transmission in the dentate of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 1973;232:331–56.
Teyler TJ, Discenna P. Long-term potentiation as a candidate mnemonic device. Brain Res Rev 1984;7:15–28.
Collingridge GL. Long-term potentiation in the hippocampus: mechanisms of initiation and modulation by neurotransmitters. TiPS 1985;6:407–11.
Linden DJ, Routtenberg A. The role of protein kinase C in long-term potentiation: a testable model. Brain Res Rev 1989;14:279–96.
Lynch MA, Errington ML, Bliss TVP. Nordihydroguaiaretic acid blocks the synaptic component of long-term potentiation and the associated increases in release of glutamate and arachidonate: anin vivo study in the dentate gyrus of the rat. Neuroscience 1989;30:693–701.
Dolphin AC, Errington ML, Bliss TVP. Long-term potentiation of the perforant pathin vivo is associated with increased glutamate release. Nature 1982;297:496–8.
Malinow R, Tsien RW. Presynaptic enhancement by whole cell recordings of long-term potentiation in hippocampal slices. Nature 1990;346:177–80.
Ascher P, Nowak L. Electrophysiological studies of NMDA receptors. Trends Neurosci 1987;10:284–8.
Watkins JC, Krogsgaard-Larsen P, Honore T. Structure—activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. TiPS 1990;11:25–33.
Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987;325:529–31.
Kleckner NW, Dingledine R. Requirement for glycine of NMDA-receptors expressed in xenopus oocytes. Science 1988;241:835–7.
Nicoll RA, Kauer JA, Malenka RC. The current excitement in long-term potentiation. Neuron 1988;1:97–103.
Collingridge GL, Bliss TVP. NMDA receptors: their role in long-term potentiation. Trends Neurosci 1987;10:288–93.
Harris EW, Cotman CW. Long-term potentiation of guinea pig mossy fibre responses is not blocked byN-methyl-D-aspartate antagonists. Neurosci Lett 1986;70:132–7.
Cotman CW, Monaghan DT, Ottersen OP, Storm-Matthisen J. Anatomical organization of excitatory amino acid receptors and their pathway. Trends Neurosci 1987;10:273–80.
Dunnett SB. Comparative effects of cholinergic drugs and lesions of nucleus basalis of fimbria-fornix on delayed matching in rats. Psychopharmacology 1985;87:357–63.
Williams S, Johnston D. Muscarinic depression of long-term potentiation in CA3 hippocampal neurons. Science 1988;242:84–7.
Hirotsu I, Hori N, Katsuda N, Ishihara T. Effect of anticholinergic drug on long-term potentiation in rat hippocampal slices. Brain Res 1989;482:194–7.
Beukers M, Meigel I, Boddeke HWGM. Effect of M1 muscarinic receptors on long-term potentiation in rat hippocampal slices. Pharm Weekbl [Sci] 1989;11 (Suppl J):J3.
Saito H, Togashi H, Matsumoto M, Morii K, Yoshioka M. Effect of a novel muscarinic agonist of the M1-type receptor on memory impairment in vascular dementiaanimals. Eur J Pharmacol 1990;183:930.
Kojima J, Yoshida S, Ishii Y, Fujii K, Okumura M. Effects of NIK-247 and 9-amino-1,2,3,4,-tetrahydroacridine on scopolamine-induced amnesia, long-term potentiation and acetylcholinesterase. Eur J Pharmacol 1990;183:929.
Stanton PK, Sarvey JM. Depletion of norepinephrine, but not serotonin, reduces long-term potentiation in the dentate gyrus of rat hippocampal slices. J Neurosci 1985;5:2169–76.
Stanton PK, Sarvey JM. Blockade of norepinephrineinduced long-lasting potentiation in the hippocampal dentate gyrus by an inhibitor of protein synthesis. Brain Res 1985;361:276–83.
Hopkins WF, Johnston D. Frequency-dependent noradrenergic modulation of long-term potentiation in the hippocampus. Science 1984;226:350–2.
Ito I, Okada D, Sugiyama H. Pertussis toxin suppresses long-term potentiation of hippocampal mossy fibre synapses. Neurosci Lett 1988;90:181–5.
Gribkoff VK, Ashe JH. Modulation by dopamine of population response and cell membrane properties of hippocampal CA1 neuronsin vitro. Brain Res 1984;292:327–38.
Van den Hoof P, Urban IJA, De Wied D. Vasopressin maintains long-term potentiation in rat lateral septum slices. Brain Res 1989;423:181–6.
Lynch G, Errington MA, Clements M, Bliss TVP. Intracellular injections of EGTA block induction of hippocampal long term potentiation. Nature 1983;305:719–21.
Gustafson B, Wigström H, Abraham WC, Huang YY. Long-term potentiation in the hippocampus using depolarizing current pulses as the conditioning stimulus to single volley synaptic potentials. J Neurosci 1987;7:774–80.
Kauer JA, Nicoll RA. An APV resistant nonassociative form of long-term potentiation in the rat hippocampus. Exp Brain Res 1988;107:45–63.
Williams JH, Errington ML, Lynch MA, Bliss TVP. Arachidonic acid induces a long-term activity dependent enhancement of synaptic transmission in the hippocampus. Nature 1989;341:739–41.
Kuo-Ping Huang. The mechanism of protein kinase C activation. Trends Neurosci 1989;12:425–32.
Linden DL, Sheu FS, Murakami K, Routtenberg A. Enhancement of long-term potentiation by cis-unsaturated fatty acid: relation to protein kinase C and phospholipase A2. J Neurosci 1987;7:3783–92.
Lynch MA, Errington ML, Bliss TVP. Nordihydroguaiaretic acid blocks the synaptic component of long-term potentiation and the associated increases in release of glutamate and arachidonate: anin vivo study in the dentate gyrus of the rat. Neuroscience 1989;30:693–701.
Williams JH, Bliss TVP. Induction but not maintenance, of calcium-induced long-term potentiation is blocked by nordihydroguaiaretic acid. Neurosci Lett 1988;88:81–5.
Williams JH, Bliss TVP. Anin vitro study of the effect of lipoxygenase and cyclo-oxygenase inhibitors of arachidonic acid on the induction and maintenance of long-term potentiation in the hippocampus. Neurosci Lett 1989;107:301–6.
Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 1984;308:639–40.
Reymann KG, Schulzeck K, Kase H, Matthies H. Phorbol ester-induced hippocampal long-term potentiation is counteracted by inhibitors of protein kinase C. Exp Brain Res 1988;71:227–30.
Muller D, Turnbull J, Baudry M, Lynch G. Phorbol ester-induced synaptic facilitation is different than long-term potentiation. Proc Natl Acad Sci 1988;85:6997–7000.
Hu GY, Hvalby Ø, Walaas SI, et al. Protein kinase C injection into hippocampal pyramidal cells elicits features of long-term potentiation. Nature 1987;324:426–9.
Lovinger D, Colley PA, Akers RF, Nelson RB, Routtenberg A. Direct relation of long-term synaptic potentiation to phosphorylation of membrane protein F1, a substrate for membrane protein kinase C. Brain Res 1986;399:205–13.
Nelson RB, Linden DJ, Routtenberg A. Phosphoproteins localized to presynaptic terminal linked to persistence of long-term potentiation (LTP): quantitative analysis of two dimensional gels. Brain Res 1989;497:30–42.
Reyman KG, Schulzeck K, Kase H, Matthies H. Phorbol ester-induced hippocampal long-term potentiation is counteracted by inhibitors of protein kinase C. Exp Brain Res 1988;71:227–30.
Malenka RC, Kauer JA, Perkel DJ, et al. An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation. Nature 1989;340:554–7.
Mondadori C, Petschke F, Haeusler A. The effects of nootropics on memory. New aspects for basic research. Pharmacopsychiatry 1989;22:102–6.
Satoh M, Ishihara K, Katsuki H. Different susceptibility of long-term potentiation in CA3 and CA1 regions of guinea pig hippocampal slices to nootropic drugs. Neurosci Lett 1988;93:236–41.
Nickolson VJ, Wolthuis OL. Effect of the acquisitionenhancing drug piracetam on rat cerebral energy metabolism. Comparison with naphtidrofuryl and methamphetamine. Biochem Pharmacol 1976;25:41–4.
Woelk H. Effects of piracetam on the incorporation of32p into the phospholipids of neurons and glial cells isolated from rabbit cerebral cortex. Pharmacopsychiatry 1979;12:251–6.
Pugsley TABH, Poschel PH, Dowens DA, Shih YH, Gluckman MI. Some pharmacological and neurochemical properties of a new cognition activator agent, piracetam (CI-879). Psychopharmacol Bull 1983;19:721–6.
Mattson RJ, Moon SL. Agents for the treatment of cognitive disorders. Ann Rep Med Chem 1988;28:519–45.
Hagihara M, Nagatsu T. Post-proline cleaving enzyme in human cerebrospinal fluid from control patients and parkinsonian patients. Biochem Med Metab Biol 1987;38:387–91.
Cherubini E, Ben Ari Y, Gho M, Bidard JN, Lazdunski M. Long-term potentiation of synaptic transmission in the hippocampus induced by a bee venom peptide. Nature 1987;328:70–3.
Ben Ari Y, Cherubini E, Aniksztejn L, Roitsin MP, Charriaut-Marlangue C. Mechanism of induction of long-term potentiation by the mast cell degranulating peptide. Pharmacopsychiatry 1989;22:107–10.
Herrling P. Clinical implications of NMDA receptors. In: Watkins J, Collingridge G, eds. The NMDA receptor. Oxford: Oxford University Press, 1989:23–39.
Enz A, Amstutz R, Hofmann A, Gmelin G, Kelly P. Pharmacological properties of the centrally acting acetylcholinesterase inhibitor SDZ ENA-713. In: Kewitz J, Thomson EF, Bickel P, eds. Clinical pharmacology. Munich: Zuckwerdt Verlag, 1988:271–7. (Pharmacological intervention on central cholinergic mechanisms in senile dementia; vol. 2).
Yamanishi Y, Ogura H, Uchikoshi K, Sawa Y, Yamatsu K. Inhibitory action of E2020, a novel acetylcholinesterase inhibitor, on cholinesterase in aged rats. Eur J Pharmacol 1990;183:1935.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beukers, M., Boddeke, E.W.G.M. Pharmacology of long-term potentiation. Pharmaceutisch Weekblad Scientific Edition 13, 7–12 (1991). https://doi.org/10.1007/BF01963877
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01963877